Dexmedetomidine Supplemented Analgesia and Incidence of Postoperative Delirium

NACompletedINTERVENTIONAL
Enrollment

1,500

Participants

Timeline

Start Date

January 6, 2017

Primary Completion Date

May 12, 2022

Study Completion Date

June 11, 2022

Conditions
ElderlySurgeryAnalgesiaDexmedetomidineComplication, PostoperativeDelirium
Interventions
DRUG

Dexmedetomidine supplemented morphine analgesia

Patients in this group will receive patient-controlled intravenous analgesia for 3 days after surgery. The formula is a mixture of dexmedetomidine (1.25 ug/ml) and morphine (0.5 mg/ml), diluted with normal saline to 160 ml. 5-HT3 receptor antagonist is added when necessary. The analgesic pump is set to administer a background infusion at a rate of 1 ml/h, with a bolus dose of 2 ml each time and a lockout time from 6 to 8 minutes according to patients' condition.

DRUG

Morphine analgesia

Patients in this group will receive patient-controlled intravenous analgesia for 3 days after surgery. The formula is morphine (0.5 mg/ml) diluted with normal saline to 160 ml. 5-HT3 receptor antagonist is added when necessary. The analgesic pump is set to administer a background infusion at a rate of 1 ml/h, with a bolus dose of 2 ml each time and a lockout time from 6 to 8 minutes according to patients' condition.

Trial Locations (11)

100034

Peking University First Hospital, Beijing

102206

Peking University International Hospital, Beijing

210009

Zhongda Hospital Southeast University, Nanjing

266011

Qingdao Municipal Hospital, Qingdao

300100

Tianjin Hospital of ITCWM-Nankai Hospital, Tianjin

408099

Chongqing University Fuling Hospital, Chongqing

410013

The Third Xiangya Hospital of Central South University, Changsha

550002

Guizhou Provincial People's Hospital, Guiyang

710038

The Second Affiliated Hospital of Air Force Medical University, Xi'an

050031

Affiliated Hospital of Hebei University, Baoding

030013

Shanxi Provincial Cancer Hospital, Taiyuan

All Listed Sponsors
collaborator

Affiliated Hospital of Hebei University

OTHER

collaborator

Qingdao Municipal Hospital

OTHER

collaborator

The Second Affiliated Hospital of Air Force Medical University

UNKNOWN

collaborator

Peking University International Hospital

OTHER

collaborator

Guizhou Provincial People's Hospital

OTHER

collaborator

The Third Xiangya Hospital of Central South University

OTHER

collaborator

Shaanxi Provincial Cancer Hospital

OTHER

collaborator

Tianjin Hospital of ITCWM-Nankai Hospital

UNKNOWN

collaborator

Zhongda Hospital

OTHER

collaborator

Chongqing University Fuling Hospital

UNKNOWN

lead

Peking University First Hospital

OTHER

NCT03012984 - Dexmedetomidine Supplemented Analgesia and Incidence of Postoperative Delirium | Biotech Hunter | Biotech Hunter